27 March 2025

Repetitive Transcranial Magnetic Stimulation in Fibromyalgia

A randomized, sham-controlled trial has shown that repetitive transcranial magnetic stimulation (rTMS) reduced pain in fibromyalgia for up to 8 weeks; while analgesic effects waned, functional improvements remained during extended maintenance at week 16.

27 March 2025

Cardiac-MSK Patients at Highest Risk for Falls and Death

A new study by researchers at Peking University and the Chinese PLA General Hospital has found that multimorbidity—living with multiple chronic diseases—is closely associated with worsening fall conditions and mortality among middle-aged and older adults in China. The findings, published in Health Data Science, identify a distinct group at especially high risk: individuals with both cardiovascular and musculoskeletal conditions, dubbed the “osteo-cardiovascular fallers.”

Peripheral Nerve Blocks for Hip Fractures JAMA reviews the use of peripheral nerve block with hip fractures as an effe

Tweet Author

RheumNow

Tweet Content

Peripheral Nerve Blocks for Hip Fractures JAMA reviews the use of peripheral nerve block with hip fractures as an effective pain management strategy that can be performed by credentialed clinicians outside of the operating room. https://t.co/baeLWVxeUo https://t.co/ZBTVDT0jGR

Links

Peripheral Nerve Blocks for Hip Fractures | RheumNow https://buff.ly/zXZZxW3

A comprehensive examination of the pathogenesis and recent advancements in Familial Mediterranean Fever (FMF). This cond

Tweet Author

RheumNow

Tweet Content

A comprehensive examination of the pathogenesis and recent advancements in Familial Mediterranean Fever (FMF). This condition results from autosomal recessive mutations in the MEFV gene, which codes for Pyrin, a crucial component of the NLRP3 inflammasome. These genetic https://t.co/XNV89LW893

A study in mice shows that JAK inhibition In mice model of status epilepticus (SE) didnt prevent initial SE but when did

Tweet Author

RheumNow

Tweet Content

A study in mice shows that JAK inhibition In mice model of status epilepticus (SE) didnt prevent initial SE but when did effect chronic phase of Sz weeks after SE induction of SE, suppressing seizures, and epilepsy-associated histopathological alterations. Sz suppression lasted https://t.co/GMIPCtoc7x

ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting n

Tweet Author

ACR_Journals

Tweet Content

ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting non-glycine citrulline motifs assoc. more strongly w/ HLA-SE; ACPA to glycine citrulline motifs assoc. w/ smoking and IgA ACPA A&R https://t.co/PmKv3dZLc4 https://t.co/NdPG4Orfj4

Links

Recognition of glycine versus non‐glycine citrulline motifs dictates the HLA cl… https://doi.org/10.1002/art.43161

https://x.com/ACR_Journals/status/1904996803986022604/photo/1

Autoimmune Disease Impact Report Integrated Benefit Institute, a nonprofit independent research organization, has publ

Tweet Author

RheumNow

Tweet Content

Autoimmune Disease Impact Report Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/TfXZti5NN3

26 March 2025

Predicting Premature Death with Multimorbidity

Machine learning (ML) models were used to predict premature death in inflammatory bowel disease (IBD) patients with multimorbidity, the co-occurrence of 2 or more chronic conditions.

26 March 2025

Worse Outcomes in HLA-B27+ JIA

Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.

25 March 2025

Treating chronic inflammatory diseases with JAK inhibitors

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since their approval, the indications for these medical drugs have steadily increased, but recently safety concerns have also been raised. In order to support the safe and efficient use of JAK inhibitors in the treatment of patients, an international panel of experts led by MedUni Vienna has published new guidelines.

Topics

Repetitive Transcranial Magnetic Stimulation in Fibromyalgia

Peripheral Nerve Blocks for Hip Fractures JAMA reviews the use of peripheral nerve block with hip fractures as an effe

A comprehensive examination of the pathogenesis and recent advancements in Familial Mediterranean Fever (FMF). This cond

A study in mice shows that JAK inhibition In mice model of status epilepticus (SE) didnt prevent initial SE but when did

ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting n

Autoimmune Disease Impact Report Integrated Benefit Institute, a nonprofit independent research organization, has publ

Do you get our email newsletter?